[go: up one dir, main page]

ID21920A - 4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns - Google Patents

4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns

Info

Publication number
ID21920A
ID21920A IDW990623A ID990623A ID21920A ID 21920 A ID21920 A ID 21920A ID W990623 A IDW990623 A ID W990623A ID 990623 A ID990623 A ID 990623A ID 21920 A ID21920 A ID 21920A
Authority
ID
Indonesia
Prior art keywords
hydropirins
tetrah
indol
cns
fluoro
Prior art date
Application number
IDW990623A
Other languages
English (en)
Indonesian (id)
Inventor
John Fairhurst
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID21920A publication Critical patent/ID21920A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW990623A 1997-01-17 1998-01-14 4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns ID21920A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700895.7A GB9700895D0 (en) 1997-01-17 1997-01-17 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ID21920A true ID21920A (id) 1999-08-12

Family

ID=10806121

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990623A ID21920A (id) 1997-01-17 1998-01-14 4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns

Country Status (29)

Country Link
US (1) US20010053783A1 (no)
EP (1) EP0854146B1 (no)
JP (1) JPH10204090A (no)
KR (1) KR20000070221A (no)
AR (1) AR011422A1 (no)
AT (1) ATE190617T1 (no)
AU (1) AU5569298A (no)
CA (1) CA2227132A1 (no)
CZ (1) CZ290318B6 (no)
DE (1) DE69800092T2 (no)
DK (1) DK0854146T3 (no)
EA (1) EA001469B1 (no)
ES (1) ES2144888T3 (no)
GB (1) GB9700895D0 (no)
GR (1) GR3033316T3 (no)
HU (1) HUP0000854A3 (no)
ID (1) ID21920A (no)
IL (1) IL129647A (no)
NO (1) NO993372L (no)
NZ (1) NZ335493A (no)
PE (1) PE99399A1 (no)
PL (1) PL334569A1 (no)
PT (1) PT854146E (no)
SI (1) SI0854146T1 (no)
SV (1) SV1998000088A (no)
TR (1) TR199901583T2 (no)
TW (1) TW396156B (no)
WO (1) WO1998031686A1 (no)
ZA (1) ZA98300B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999010346A1 (en) * 1997-08-22 1999-03-04 Eli Lilly And Company Limited Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
GB9825413D0 (en) 1998-11-19 1999-01-13 Lilly Co Eli Pharmaceutical compounds
GB9903784D0 (en) * 1999-02-18 1999-04-14 Lilly Co Eli Pharmaceutical compounds
AR028945A1 (es) * 2000-06-19 2003-05-28 Lundbeck & Co As H Derivados de indol
KR101165996B1 (ko) 2010-04-23 2012-07-18 주식회사 녹십자 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
CN105949190B (zh) * 2016-07-04 2018-06-29 烟台凯博医药科技有限公司 一种制备1，8-萘啶及衍生物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
PT854146E (pt) 2000-08-31
PL334569A1 (en) 2000-03-13
ES2144888T3 (es) 2000-06-16
ATE190617T1 (de) 2000-04-15
AU5569298A (en) 1998-08-07
EA001469B1 (ru) 2001-04-23
CZ290318B6 (cs) 2002-07-17
NO993372D0 (no) 1999-07-08
EP0854146B1 (en) 2000-03-15
HUP0000854A2 (hu) 2000-11-28
EA199900667A1 (ru) 2000-02-28
SI0854146T1 (en) 2000-10-31
EP0854146A1 (en) 1998-07-22
US20010053783A1 (en) 2001-12-20
ZA98300B (en) 1998-09-10
NO993372L (no) 1999-07-08
DE69800092T2 (de) 2000-09-14
HUP0000854A3 (en) 2002-06-28
PE99399A1 (es) 1999-11-11
SV1998000088A (es) 2000-10-10
DK0854146T3 (da) 2000-06-05
IL129647A0 (en) 2000-02-29
WO1998031686A1 (en) 1998-07-23
DE69800092D1 (de) 2000-04-20
TW396156B (en) 2000-07-01
GR3033316T3 (en) 2000-09-29
AR011422A1 (es) 2000-08-16
CZ151099A3 (cs) 1999-09-15
TR199901583T2 (xx) 1999-11-22
KR20000070221A (ko) 2000-11-25
JPH10204090A (ja) 1998-08-04
GB9700895D0 (en) 1997-03-05
IL129647A (en) 2002-02-10
NZ335493A (en) 2000-09-29
CA2227132A1 (en) 1998-07-17

Similar Documents

Publication Publication Date Title
FR2725204B1 (fr) 2-hydroxyphenyltriazines comme agents photostabilisants
NO975775L (no) Fremgangsmåte for fremstilling av forbindelser med antifungal aktivitet
EP0719765A3 (en) Phenylbenzimidazole derivatives
BR9608569A (pt) Compostos não tecidos hidroemaranhados
PT841924E (pt) Compostos de benzimidazolo
DE69616396D1 (de) Benzothiophen-Verbindungen, Zwischenprodukte, Zusammensetzungen und Verfahren
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
ID17723A (id) Senyawa untuk pengobatan
EP1023250A4 (en) METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE
NO20003211D0 (no) Triazinforbindelser for behandling av CNS forstyrrelser
NO993949D0 (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
ID21920A (id) 4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns
NO20005424L (no) Fremgangsmåte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
ZA968550B (en) Novel processes for the preparation of anti-malarial compounds.
ID24327A (id) Produksi senyawa-senyawa avermektin
BR9706702A (pt) Purificação de 1,1,1,3,3-pentafluorpropano
FI964410A7 (fi) Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delt a4-3-ketosteroidien kautta
FI943833A0 (fi) Menetelmä 2,3,5,6-tetraklooripyridiinin valmistamiseksi
NO20005425D0 (no) FremgangsmÕte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
ID26083A (id) Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns
IT1290151B1 (it) Procedimento migliorato per la produzione di 5-idrossimetiltiazolo